← Back to Clinical Trials
Recruiting NCT07814690

NCT07814690 Evaluation of Foreign Body Airway Obstruction Interventions: A Prospective Cohort Study of Adults and Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07814690
Status Recruiting
Phase —
Sponsor University of Calgary
Condition Choking
Study Type OBSERVATIONAL
Enrollment 640 participants
Start Date 2026-05-01
Primary Completion 2030-06-30

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 640 participants in total. It began in 2026-05-01 with a primary completion date of 2030-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Foreign body airway obstruction (FBAO, choking) is a life-threatening emergency requiring time-sensitive treatment to prevent severe injury or deaths. Traditional treatments taught in first aid courses include abdominal thrusts, back blows, and chest compressions or thrusts. Currently, first aid guidelines recommend different treatments for adults, child and infants. Until recently, data on these techniques was limited to case series from the late 1900's. To further improve our knowledge of which treatment is most effective and safest for patients, this study will collect data on choking incidents in Alberta, Canada. This study will focus on adults and children over the age of 2 years.

Eligibility Criteria

Inclusion Criteria: * Adult or children (aged greater than 2 years) who experienced an out-of-hospital FBAO in Alberta, Canada * Received a FBAO intervention by bystander or healthcare provider * Were assessed by EMS at the time of the incident, or later attended an emergency department due to the incident Exclusion Criteria: \- Patients with abnormal airway anatomy such as a tracheostomy.

Contact & Investigator

Central Contact

Cody Dunne, MD

✉ cody.dunne@ucalgary.ca

📞 000-000-0000

Principal Investigator

Cody Dunne, MD

PRINCIPAL INVESTIGATOR

University of Calgary

Frequently Asked Questions

Who can join the NCT07814690 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, studying Choking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07814690 currently recruiting?

Yes, NCT07814690 is actively recruiting participants. Contact the research team at cody.dunne@ucalgary.ca for enrollment information.

Where is the NCT07814690 trial being conducted?

This trial is being conducted at Calgary, Canada.

Who is sponsoring the NCT07814690 clinical trial?

NCT07814690 is sponsored by University of Calgary. The principal investigator is Cody Dunne, MD at University of Calgary. The trial plans to enroll 640 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology